Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00268227
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
C62 | 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN- 5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE | A | 2UZO | 0.71 | |
AGG | TIROFIBAN | A,B | 2VDM | 0.72 | |
MTJ | N,O-DIMETHYL-L-TYROSINE | A,B | 1ATL | 0.75 | |
K55 | (2S)-2-{4-butoxy-3-[({[2-fluoro- 4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]benzyl}butanoic acid | A,B | 2ZNP | 0.72 | |
DCH | 3-(7-DIAMINOMETHYL-NAPHTHALEN-2- YL)-PROPIONIC ACID ETHYL ESTER | H | 1UVU | 0.76 | |
JT6 | 3-[(4'-cyanobiphenyl-4-yl)oxy]- N-hydroxypropanamide | A | 2JT6 | 0.73 | |
C39 | N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)- 8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE | C,O | 2V12 | 0.72 | |
3AC | (2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL- 2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE | A | 2B5J | 0.7 | |
PI1 | A,B | 1B6J | 0.75 | ||
Y12 | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP- 1-EN-1-YL}-1,2-PHENYLENE DIACETATE | A | 2EW5 | 0.71 | |
0EZ | tert-butyl [(1S,2S)-1-benzyl-2- hydroxy-3-{[(8S,11R)-8-[(1R)-1- methylpropyl]-7,10-dioxo-2-oxa- 6,9-diazabicyclo[11.2.2]heptadeca- 1(15),13,16-trien-11-yl]amino}propyl]carbamate | A,B | 1MTR | 0.72 | |
TF3 | N-(2-AMINOETHYL)-2-{3-CHLORO-4- [(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | A | 2BU7 | 0.78 | |
DEO | A,B | 1ROS | 0.74 | ||
SFX | (3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan- 1-amine | A | 3GWW | 0.72 | |
PI8 | N-13-[(10S,13S)-9,12-DIOXO-10-(2- BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA- 15,17,18-TRIENE] (2R)-BENZYL-(4S)- HYDROXY-5-AMINOPENTANOIC (1R)-HYDROXY- (2S)-INDANEAMIDE | A,B | 1D4K | 0.7 | |
TRT | FRAGMENT OF TRITON X-100 | A,E | 2I0U | 0.7 | |
TRT | FRAGMENT OF TRITON X-100 | A,B | 1OIZ | 0.7 | |
3MB | 3-METHOXYBENZAMIDE | A | 3PAX | 0.76 | |
HA2 | 6-[{(2S)-2-AMINO-3-[4-(BENZYLOXY)PHENYL]PROPYL}(HYDROXY)AMINO]- 6-OXOHEXANOIC ACID) | A | 2VJ8 | 0.74 | |
R22 | 4-(3,5-DIMETHYLPHENOXY)-5-(FURAN- 2-YLMETHYLSULFANYLMETHYL)-3-IODO- 6-METHYLPYRIDIN-2(1H)-ONE | A,B | 2BE2 | 0.7 | |
FIR | (2R,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 1X97 | 0.74 | |
RFX | (3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan- 1-amine | A | 3GWV | 0.72 | |
BBB | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE- 2,4(1H,3H)-DIONE | A,B,C,D,E,F | 1U1G | 0.71 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PDW | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2AGT | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PF8 | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PFH | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 1PWM | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PEV | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PDY | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A,B | 1EF3 | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 2PD9 | 0.74 | |
FID | (2S,4S)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 3H4G | 0.74 | |
FIS | (2S,4R)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 3BCJ | 0.74 | |
FIS | (2S,4R)-2-AMINOFORMYL-6-FLUORO- SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]- 2',5'-DIONE | A | 1X98 | 0.74 | |
PI7 | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2- OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA- 1(16),13(17),14-TRIEN-11-YAMINO)- 2-HYDROXY-1-(4-HYDROXY-BENZYL) - PROPYL]-3-METHYL-2-PROPIONYLAMINO- BUTYRAMIDE | A,B | 1B6P | 0.73 | |
DRR | A,B | 3BXR | 0.77 | ||
IC1 | 3-[(2,4,6-TRIMETHOXY-PHENYL)-METHYLENE]- INDOLIN-2-ONE | A,B | 1EH4 | 0.7 | |
C41 | ALISKIREN | C,O | 2V0Z | 0.74 | |
ZHZ | 2-(4-METHOXYPHENYL)ACETAMIDE | D,H | 2HKR | 0.84 | |
5RM | (5R)-5-(4-methoxy-3-propoxyphenyl)- 5-methyl-1,3-oxazolidin-2-one | A,B | 1XM6 | 0.73 | |
C40 | N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]- 2-(3-METHOXYPROPOXY)BENZAMIDE | A | 2V13 | 0.71 | |
TDZ | (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8- TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN- 2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE- 2,4-DIONE | A,B | 2QM9 | 0.75 | |
TDZ | (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8- TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN- 2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE- 2,4-DIONE | A | 2VN0 | 0.75 | |
HTA | N-[3-(N'-HYDROXYCARBOXAMIDO)-2- (2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE- N-METHYLAMIDE | A | 1FBL | 0.78 | |
PI4 | 1-[2-(8-CARBAMOYLMETHYL-6,9-DIOXO- 2-OXA-7,10-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14-TRIEN-11-YL)-2- HYDROXY-ETHYL]-PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1B6L | 0.73 | |
BHP | (S)-5-(4-BENZYLOXY-PHENYL)-4-(7- PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID | A,B | 1J1A | 0.77 | |
4SR | (4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN- 2-ONE | A,B | 1XN0 | 0.85 | |
ZHH | 2-(4-METHOXYPHENYL)ETHANAMINE | D,H | 2HKR | 0.73 | |
PI5 | N-[3-(8-SEC-BUTYL-7,10-DIOXO-2- OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14- TRIEN-11-YLAMINO)- 2-HYDROXY-1-(4-HYDROXY-BENZYL)- PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN- 1-YL)-BUTYRAMIDE | A,B | 1B6K | 0.75 | |
C61 | (2R,4S,5S,7S)-5-AMINO-N-BUTYL-4- HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]- 2,8-DIMETHYLNONANAMIDE | C,O | 2V10 | 0.76 | |
2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OTF | 0.79 | |
2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2NUV | 0.79 | |
2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OUB | 0.79 | |
462 | N-[amino(imino)methyl]-2-[2-(2- chlorophenyl)-4-(4-propoxyphenyl)- 3-thienyl]acetamide | A | 2QU3 | 0.7 | |
TAX | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)- PHENOXY]-N,N-DIMETHYLETHANAMINIUM | A | 1FJ5 | 0.7 | |
D18 | 2,5-BIS{[4-(N-ISOPROPYL)DIAMINOMETHYL]PHENYL}FURAN | B | 298D | 0.71 | |
ROL | ROLIPRAM | A,B,C,D | 1OYN | 0.85 | |
ROL | ROLIPRAM | A,B | 1XMY | 0.85 | |
ROL | ROLIPRAM | A,B,C,D | 1Q9M | 0.85 | |
ROL | ROLIPRAM | A,B | 1RO6 | 0.85 | |
ROL | ROLIPRAM | A,B | 1XN0 | 0.85 | |
ROL | ROLIPRAM | A,B | 1TBB | 0.85 | |
FMX | FAMOXADONE | C,D,E | 1L0L | 0.7 | |
PI6 | [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO- 2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA- 1(16),13(17),14-TRIEN-11-YLAMINO)- 2-HYDROXY-PROPYL] -CARBAMIC ACID TERT- BUTYL ESTER | A,B | 1B6M | 0.72 | |
SGI | 3-(4-hydroxyphenyl)propanamide | A,B | 2R9K | 0.72 | |
NHN | A,C | 2GVF | 0.71 | ||
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.71 | |
4MP | 1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE | A,B | 2AL5 | 0.77 | |
DRS | (9S,12S)-9-(1-methylethyl)-7,10- dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca- 1(16),14,17-triene-12-carboxylic acid | A,B | 3BXS | 0.76 | |
ANM | ANISOMYCIN | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1K73 | 0.73 | |
ANM | ANISOMYCIN | 0,1,3,9,A,B, C,F,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3CC4 | 0.73 | |
SBI | SORBINIL | A | 1AH0 | 0.77 | |
SBI | SORBINIL | A | 2PDK | 0.77 | |
NBF | [(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID | A | 1NY0 | 0.74 | |
NBF | [(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID | A,B | 1YMS | 0.74 | |
11N | 1-[1'-(3-phenylacryloyl)spiro[1- benzofuran-3,4'-piperidin]-5-yl]methanamine | A,B,C,D | 2ZEC | 0.71 | |
HQQ | 5-METHYL-5-(4-PHENOXY-PHENYL)-PYRIMIDINE- 2,4,6-TRIONE | A,B,C | 1G4K | 0.79 |